News and Announcements

Cellmid Signs Midkine Diagnostic Agreement

Published February 11, 2013 10:47AM UTC
Publisher Wholesale Investor
Categories Company Updates

Option to License agreement signed for the Company’s diagnostic technology
Cellmid to receive an upfront option fee and supply its diagnostic antibodies
Multiple cancer diagnostic products are expected to be developed
Agreement further validates Cellmid’s midkine diagnostic technology

SYDNEY, Monday, 11 February 2013: Cellmid Limited (ASX: CDY) has signed an important option agreement with listed Japanese company Fujikura Kasei Co Ltd, a major supplier of latex particles used in medical diagnostics.

Under the terms of the Option to License agreement Cellmid will supply its proprietary anti-midkine diagnostic antibodies for validation on Fujikura’s latex platform. Cellmid will receive an initial fee and a further payment should Fujikura elect to exercise its license option. Cellmid will also receive royalties on any future midkine diagnostic products sold by Fujikura.

To read full ASX announcement, please download the document below.

Company Updates

View All

Capital Insights

The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights

The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Capital Insights

Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors

Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]

View All